Studies on cultured hippocampal neurons have led to a model of axon specification in which young neurons start out with a number of neurites that are all equally likely to differentiate into the axon (Craig and Banker, 1994) . In this model, the stochastic accumulation of one or several key components in one of the neurites makes it grow faster than the others and become the axon. A positive feedback loop acting in the emerging axon is then thought to fortify the axonal fate of this neurite. Additionally, an inhibitory, negative feedback signal may emanate from the axon to prevent the other neurites from also choosing axonal fates. Importantly, both intracellular asymmetry as well as extracellular cues might be able to impart a growth advantage to one neurite, leading to axon formation. Viewing axon specification as a competition between several equivalent neurites (as seen in culture) might not be adequate to account for axon formation in vivo. Two papers in this issue of Cell (Barnes et al., 2007; Shelly et al., 2007) show that external cues can act through the serine/threonine kinase LKB1 and the downstream SAD kinases to specify the axon both in vitro and in vivo.
The first molecules shown to regulate axon specification in cultured neurons were the polarity proteins par3/par6 and atypical protein kinase C, acting downstream of PI3-kinase. Since then, many additional players have been shown to accumulate in the growing axon and to affect formation of the axon (reviewed in Arimura and Kaibuchi, 2007) . For most of these proteins, downregulation or inhibition of their activity disrupts the formation of an axon, whereas overexpression leads to the formation of multiple axons. Importantly, for a few proteins, such as the kinase GSK3β, the opposite is the case: downregulation leads to the formation of multiple axons and overexpression disrupts axon formation. Now, Barnes et al. (2007) and Shelly et al. (2007) identify a new player in axon specification, the tumor suppressor protein LKB1, a protein that also controls epithelial polarity. Barnes et al. (2007) disrupted expression of LKB1 in the murine neocortex using a conditional knockout approach to demonstrate that LKB1 is required for axonogenesis. In these mice, neuronal migration and cortical layering is largely normal, but no axons are formed. They also show that activated LKB1 in a complex with the pseudokinase STRAD in the neocortex is the major activator of a set of downstream kinases, SAD-A and SAD-B, which are upstream of tau phosphorylation. Given the striking penetrance of the phenotype of the knockout mouse, there is no evidence that redundant pathways independent of LKB1 exist for axon formation in the neocortex.
In complementary work, Shelly et al. (2007) initially characterized the role of LKB1 in axon formation in cultured neurons. They then confirmed its importance in vivo using in utero electroporation of plasmids that express an siRNA to knockdown expression of LKB1 in rat embryos. They also identify extracellular brain-derived neurotrophic factor (BDNF) as an upstream activator of LKB1 via the elevation of intracellular cAMP. Importantly, local presentation of BDNF in culture bypasses the requirement for PI3K activation and leads to axon formation even in the presence of PI3K inhibitors. The exact interrelationship between the LKB1/STRAD and PI3K signaling cascades remains to be determined. The work by Shelly et al. (2007) also suggests that activated LKB1, when in a trimeric complex with STRAD and MO25, is part of a positive feedback loop for continued LKB1 signaling in the growing axon. An additional mechanism for positive feedback is provided by the Rho family GTPase Rac, which is both downstream and upstream of PI3K (Arimura and Kaibuchi, 2007) .
In contrast, the molecular components involved in the postulated long distance negative feedback are unknown. Interestingly, GSK3β is constitutively active in all neurites, thereby locally inhibiting important regulators of axon growth, such as CRMP2 (Arimura and Kaibuchi, 2007) . This inhibition is relieved locally by activation of kinases that inactivate GSK3β in the growing axon (Arimura and Kaibuchi, 2007) . Protein degradation of key axonal components by the ubiquitin proteasome system in the minor neurites provides an additional negative regulatory mechanism that is necessary for axon formation (Schwamborn et al., 2007; Yan et al., 2006) . Whether a negative regulatory molecule is generated in and emanates from the axon (rather than just acting locally at growth
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Bettina Winckler 1, * cones) to suppress growth in the other neurites awaits further study. However, it is clear that the negative feedback can be overridden, because many experimental conditions lead to the formation of multiple axons. Axon specification can be conceptualized in two ways (Arimura and Kaibuchi, 2007; Bradke and Dotti, 2000) . In the first, "axon fate" is determined by the accumulation of axon-specifying components in one neurite, and accelerated growth is one of the axonspecific responses set in motion downstream of "axonal fate" signaling. In the second, accelerated growth is the crucial initial step in axonogenesis that leads to the preferential accumulation of key axonal components in the fast growing process and acquisition of "axonal fate" downstream of growth. Several pieces of evidence suggest that growth promotion might in fact be sufficient for generating an axon (Bradke and Dotti, 2000) . The fast-growing neurite receives the bulk of cytoplasmic material in a nonspecific manner (Bradke and Dotti, 2000) , which could lead to the preferential accumulation of axon-specific modifiers of microtubules and actin, ultimately resulting in the differentiation of the fast-growing process into an axon. Work in other model systems (such as Caenorhabditis elegans) has revealed that molecules that guide and promote axon growth (such as netrins and Wnt) also promote correct axon specification (for example, see Adler et al., 2006) . Therefore, examining axon outgrowth in vivo becomes an important part of resolving how "fate" and "growth" are related.
A strength of the two papers in this issue is their in vivo analysis of axonogenesis in the developing neocortex. Clearly, insights gained in cultured hippocampal neurons have relevance in vivo, and cultured neurons remain a powerful model system. Yet, axonogenesis in the neocortex occurs differently than in cultured neurons. Most significantly, imaging the cortical migration of newborn neurons has demonstrated that axons form as neurons migrate to their correct cortical layer. The migrating cell elaborates both a leading and a trailing process. The trailing process grows into the axon, whereas the leading process becomes the major apical dendrite (Hatanaka and Murakami, 2002; Noctor et al., 2004) . Rather than axon formation being the result of the competition between several equivalent neurites, the direction of migration sets up the polarity of axon emergence. Other neuronal cell types have their own specific patterns of migration and of axon emergence, and the interrelationship between migratory direction and axon formation might be different for different cell types. Thus, studying axon growth in the context of neuronal migration in vivo will continue to reveal important insights into the processes that underlie axon specification.
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